Instil Bio TIL
NASDAQ TIL
$7.40 -0.11 (-1.46%)
As of: Sep 10, 2026 · 3:17 PM EDT

Instil Bio (TIL) Non-Current Assets (2020 - 2026)

Instil Bio (TIL) posted Non-Current Assets of $126.1 million for Q2 2026, up 939.97% on a QoQ basis from $12.1 million in Q1 2026, and up 434.35% year-over-year from $23.6 million in Q2 2025.

Analysis

Instil Bio (TIL) Non-Current Assets (2020 - 2026) Analysis & Trends

Instil Bio has reported Non-Current Assets for 7 years, with the latest figure at $126.1 million in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 434.35% year-over-year to $126.1 million in Q2 2026; TTM through Jun 2026 was $165.8 million, a 48.32% decrease from a year earlier, with the FY2025 full-year figure at $12.1 million, down 91.31% from the prior year.
  • Non-Current Assets was $126.1 million for Q2 2026 at Instil Bio, up from $12.1 million in the prior quarter.
  • The five-year high for Non-Current Assets was $219.1 million in Q3 2022, with the low at $12.1 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $125.7 million, with a median of $142.3 million recorded in 2023.
  • The sharpest annual moves came in 2025 and 2026: Non-Current Assets tumbled 91.31% in 2025, then soared 434.35% in 2026.
  • Over 5 years, Non-Current Assets stood at $212.8 million in 2022, then declined by 22.5% to $164.9 million in 2023, then dropped by 15.63% to $139.1 million in 2024, then sank by 91.31% to $12.1 million in 2025, then jumped by 942.72% to $126.1 million in 2026.
  • The last three Non-Current Assets figures came in at $126.1 million (Q2 2026), $12.1 million (Q1 2026), and $12.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.96 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 564.41 Mn
10 Instil Bio 50.19 Mn 50.19 Mn - 126.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 126.11 Mn
Mar 31, 2026 12.13 Mn
Dec 31, 2025 12.09 Mn
Sep 30, 2025 15.50 Mn
Jun 30, 2025 23.60 Mn
Mar 31, 2025 18.19 Mn
Dec 31, 2024 139.10 Mn
Sep 30, 2024 139.99 Mn
Jun 30, 2024 139.39 Mn
Mar 31, 2024 145.27 Mn
Dec 31, 2023 164.87 Mn
Sep 30, 2023 144.64 Mn
Jun 30, 2023 187.72 Mn
Mar 31, 2023 187.05 Mn
Dec 31, 2022 212.75 Mn
Sep 30, 2022 219.09 Mn
Jun 30, 2022 200.86 Mn
Mar 31, 2022 174.24 Mn
Dec 31, 2021 145.96 Mn
Sep 30, 2021 124.31 Mn